open access

Vol 79, No 9 (2008)
ARTICLES
Get Citation

Leptin gene, leptin gene receptor polymorphisms and body weight in pregnant women with type 1 diabetes mellitus

Jacek Brązert, Krzysztof Drews, Agnieszka Seremak-Mrozikiewicz, Ewa Wender-Ożegowska, Rafał Iciek, Marek Pietryga
Ginekol Pol 2008;79(9).

open access

Vol 79, No 9 (2008)
ARTICLES

Abstract

Summary Leptin, as well as many other hormones, may play an important role in the pathogenesis of obesity. Several genetic variants of both leptin and its receptor genes may influence human body weight. Aim: To investigate the role of leptin gene polymorphism promotion region (-2548G/A) and leptin gene receptor polymorphism (668 A/G) in regulation of body weight in the group of women with type 1 diabetes (PGDM-1). Methods: 78 PGDM-1 first trimester pregnant women were qualified for the study group (SG). They were divided into normal and overweight subgroups, based on pre-pregnancy BMI. Control group (CG) consisted of first trimester healthy pregnant women with normal pre-pregnancy body weight. Genetic variants of leptin gene and its receptor were analyzed with the help of PCR-RFLP assays. In the SG, the following metabolic parameters were estimated: MBG, HbA1C, insulin dose, LDL, HDL, T-CHOL, triglycerids, creatinine, creatinine clearance and blood pressure. Results: A tendency for the majority of homozygous A and G variants in LEP -2548 G/A and LEPR 668 A/G was found in overweight and obese patients, in comparison to normal-weight subjects. No specific differences in selected first trimester metabolic parameters were found in relation to patients’ genotypes in the diabetic group.

Abstract

Summary Leptin, as well as many other hormones, may play an important role in the pathogenesis of obesity. Several genetic variants of both leptin and its receptor genes may influence human body weight. Aim: To investigate the role of leptin gene polymorphism promotion region (-2548G/A) and leptin gene receptor polymorphism (668 A/G) in regulation of body weight in the group of women with type 1 diabetes (PGDM-1). Methods: 78 PGDM-1 first trimester pregnant women were qualified for the study group (SG). They were divided into normal and overweight subgroups, based on pre-pregnancy BMI. Control group (CG) consisted of first trimester healthy pregnant women with normal pre-pregnancy body weight. Genetic variants of leptin gene and its receptor were analyzed with the help of PCR-RFLP assays. In the SG, the following metabolic parameters were estimated: MBG, HbA1C, insulin dose, LDL, HDL, T-CHOL, triglycerids, creatinine, creatinine clearance and blood pressure. Results: A tendency for the majority of homozygous A and G variants in LEP -2548 G/A and LEPR 668 A/G was found in overweight and obese patients, in comparison to normal-weight subjects. No specific differences in selected first trimester metabolic parameters were found in relation to patients’ genotypes in the diabetic group.
Get Citation

Keywords

obesity, Body Mass Index - BMI, Diabetes mellitus, gene leptin receptor, gene, leptin

About this article
Title

Leptin gene, leptin gene receptor polymorphisms and body weight in pregnant women with type 1 diabetes mellitus

Journal

Ginekologia Polska

Issue

Vol 79, No 9 (2008)

Bibliographic record

Ginekol Pol 2008;79(9).

Keywords

obesity
Body Mass Index - BMI
Diabetes mellitus
gene leptin receptor
gene
leptin

Authors

Jacek Brązert
Krzysztof Drews
Agnieszka Seremak-Mrozikiewicz
Ewa Wender-Ożegowska
Rafał Iciek
Marek Pietryga

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl